New psychoactive substances: reducing the harm caused by untested drugs and an unregulated market.

Medical Journal of AustraliaVolume 201, Issue 6 p. 310-311 Editorial New psychoactive substances: reducing the harm caused by untested drugs and an unregulated market Alex D Wodak FRACP, FAChAM, FAFPHM, Corresponding Author Alex D Wodak FRACP, FAChAM, FAFPHM Emeritus Consultant [email protected] Alcohol and Drug Service, St Vincent's Hospital, Sydney, NSW.Correspondence: [email protected]Search for more papers by this author Alex D Wodak FRACP, FAChAM, FAFPHM, Corresponding Author Alex D Wodak FRACP, FAChAM, FAFPHM Emeritus Consultant [email protected] Alcohol and Drug Service, St Vincent's Hospital, Sydney, NSW.Correspondence: [email protected]Search for more papers by this author First published: 08 September 2014 https://doi.org/10.5694/mja14.01138Citations: 3Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 European Monitoring Centre for Drugs and Drug Addiction, Europol. EU drug markets report: a strategic analysis. Lisbon: Europol, 2013. http://www.emcdda.europa.eu/attachements.cfm/att_194336_EN_TD3112366ENC.pdf (accessed Aug 2014). 2 National Drug Strategy. Framework for a national response to new psychoactive substances. 7 Jul 2014. http://www.nationaldrugstrategy.gov.au/internet/drugstrategy/Publishing.nsf/content/fw-psychoactive (accessed Aug 2014). 3 New Zealand Parliament. Psychoactive Substances Bill — third reading. 11 Jul 2013. http://www.parliament.nz/en-nz/pb/debates/debates/50HansD_20130711_00000044/psychoactive-substances-bill-%E2%80%94-third-reading (accessed Aug 2014). 4Newberry J, Wodak A, Sellman D, Robinson G. New Zealand's regulation of new psychoactive substances. BMJ 2014; 348: g1534. 5 NZ Drug Foundation. Psychoactive Substances Act. Overview. http://www.drugfoundation.org.nz/psychoactive-substances-bill/history (accessed Aug 2014). 6 Global Commission on Drug Policy. War on drugs. Rio de Janeiro: GCDP, 2011. http://www.globalcommissionondrugs.org/wp-content/themes/gcdp_v1/pdf/Global_Commission_Report_English.pdf (accessed Aug 2014). 7Wodak A. The abject failure of drug prohibition. Aust N Z J Criminol 2014; 47: 190–201. 8Westermeyer J. The pro-heroin effects of anti-opium laws in Asia. Arch Gen Psychiatry 1976; 33: 1135–1139. 9Abbott A. Interview with Neil Mitchell, Radio 3AW [transcript]. 29 Apr 2014. https://www.pm.gov.au/media/2014-04-29/interview-neil-mitchell-radio-3aw (accessed Aug 2014). 10Douglas R, Wodak A, McDonald D. Alternatives to prohibition. Illicit drugs: how we can stop killing and criminalising young Australians. Canberra: Australia21, 2012. http://www.australia21.org.au/wp-content/uploads/2013/11/ASIllicitDrugsR2.pdf (accessed Aug 2014). 11 Pew Research Center for the People and the Press. America's new drug policy landscape. 2 Apr 2014. http://www.people-press.org/2014/04/02/americas-new-drug-policy-landscape (accessed Aug 2014). Citing Literature Volume201, Issue6September 2014Pages 310-311 ReferencesRelatedInformation